November 6th, 2011 by Bryan Vartabedian, M.D. in Opinion
No Comments »
I saw it begin to happen in the ’90′s. Residents came to rounds with their daily notes produced on a word processor. The notes were impressive. Legible, lengthy and meticulously detailed at first glance.
Then I started to notice a pattern. The impressive notes began to look very much alike. The thorough exam varied little from patient to patient. And problems that occurred on previous days seemed to persist in the medical record, even when it had resolved. In some cases the previous day’s note was printed only to have one or two additional elements added by hand. It was never really clear what was worse: the lack of effort or the illegible writing.
Our electronic health records (EHR) offer similar options. We can smart text our way to clinical efficiency. Some doctors have entire impressions and elements of the history pre-generated for common conditions. These are advertised features of the most common EHRs. Technology can make us look Read more »
*This blog post was originally published at 33 Charts*
November 5th, 2011 by MuinKhouryMDPhD in Opinion, Research
No Comments »
The popular proverbial saying “you cannot have your cake and eat it too” implies that one cannot consume something and preserve it at the same time–in other words, we cannot have it both ways. Well, for once, maybe we can have our cake–our whole genome sequence (WGS)–and eat it too. I believe having our WGS and consuming it in small bite sizes over a lifetime may be the only way to integrate it into medicine and public health.
Rapid advances in genomic sequencing technologies are making the possibility of reliable and affordable whole genome sequencing (WGS) a reality in the next few years. We all carry about 6 billion base pairs of DNA in each of our cells, with 5-10 million inherited variants that are different among us. This genetic variation along with environmental influences provides a blueprint for health throughout the life span, and is related to virtually every disease of public health significance. There is definite interest among the public and scientists about the personal utility of this information. In a recent survey by Nature, attitudes towards genome sequencing were explored among a sample dominated by scientists and professionals from medicine and public health. Although only 18.2% of respondents had had their genome sequenced or analyzed, 2/3 of those who had not reported they would take the opportunity should it arise. Curiosity was reported as the main single factor influencing respondents.
Can this information be useful today in improving medical care and preventing disease? Read more »
*This blog post was originally published at Genomics and Health Impact Blog*
November 5th, 2011 by Berci in Announcements
No Comments »
There is a new social campaign being launched right now on Webicina.com that curates the medical resources of social media in 80 topics in 18 languages:
We receive hundreds of suggestions from empowered patients and medical professionals every week about which social media resources should be included in our selections, and we thought we must find a way to let them know how much we appreciate their help.
So now we kindly ask you to tell us your story about how social media helped you improve your health management or helped you get better in your specialty in order to win grand prizes.
As we curate resources in basically all the social media platforms, you can tell your story in any platforms from Twitter and Facebook to blogs and Youtube. Your submissions will be Read more »
*This blog post was originally published at ScienceRoll*
November 3rd, 2011 by Medgadget in Research
No Comments »
Medtronic received the go-ahead to begin an at-home U.S. trial of its Low Glucose Suspend technology that aims to prevent hypoglycemia by automatically stopping basal insulin delivery when measured glucose reaches a critically low level.
The pump technology is already available in Europe on the company’s Paradigm Veo insulin pump.
This is the second phase of the ASPIRE (Automation to Simulate Pancreatic Insulin REsponse) study, following the completion of the in-patient clinical study. ASPIRE is a multi-center, randomized, pivotal in-home study being conducted at multiple investigational centers to determine the safety and efficacy of the Low Glucose Suspend feature in the sensor-augmented MiniMed Paradigm insulin pump. Medtronic’s newest continuous glucose sensor, the Enlite™ sensor, will be tested as part of the overall system.
ASPIRE will compare Read more »
*This blog post was originally published at Medgadget*
November 3rd, 2011 by Dinah Miller, M.D. in Opinion
No Comments »
Next week, it will be my turn to write our article for the Clinical Psychiatry News website. Over there, we try to have our writing more specifically aimed at an audience of psychiatrists. I’m going to be writing an article on Siri and the Psychiatrist….in honor of my new iPhone 4s and the “personal assistant” function named Siri. Okay, I’m obsessed. Everyday, I find new things it can help me with. Today, I asked it, “What’s the meaning of life.” What, you don’t ask your cell phone the finer existential questions? Siri answered, “All available evidence suggests chocolate.” Wow! How old is Liza Minelli? 65 years, 7 months, 20 days. Calculate a tip? No problem. Convert Celius to Fahrenheit? A cinch. And she takes dictation. “Siri, please text Patient A Read more »
*This blog post was originally published at Shrink Rap*
